Presentation is loading. Please wait.

Presentation is loading. Please wait.

Redesigning Care to Lower Episode Costs in Bone Marrow Transplantation

Published byTimo-Pekka Palo Modified over 5 years ago

Similar presentations

Presentation on theme: "Redesigning Care to Lower Episode Costs in Bone Marrow Transplantation"— Presentation transcript:

1 Redesigning Care to Lower Episode Costs in Bone Marrow Transplantation
Laura Adams, Diana Patterson, Laura Johnston, Ning Tang, Christine McMurdo, Susan Chang  Biology of Blood and Marrow Transplantation  Volume 23, Issue 3, Pages S149-S150 (March 2017) DOI: /j.bbmt Copyright © Terms and Conditions

2 Biology of Blood and Marrow Transplantation 2017 23, S149-S150DOI: (10
Biology of Blood and Marrow Transplantation  , S149-S150DOI: ( /j.bbmt ) Copyright © Terms and Conditions

3 Biology of Blood and Marrow Transplantation 2017 23, S149-S150DOI: (10
Biology of Blood and Marrow Transplantation  , S149-S150DOI: ( /j.bbmt ) Copyright © Terms and Conditions

4 Biology of Blood and Marrow Transplantation 2017 23, S149-S150DOI: (10
Biology of Blood and Marrow Transplantation  , S149-S150DOI: ( /j.bbmt ) Copyright © Terms and Conditions

Download ppt "Redesigning Care to Lower Episode Costs in Bone Marrow Transplantation"

Similar presentations

Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 

Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 
Improvement of Disease Status Determination and Documentation Pre- and Post- Transplant  Michelle Bycko, Crystal Gazaway, Jennifer Holter Chakrabarty,

Improvement of Disease Status Determination and Documentation Pre- and Post- Transplant  Michelle Bycko, Crystal Gazaway, Jennifer Holter Chakrabarty,
How to Treat MDS without Stem Cell Transplantation

How to Treat MDS without Stem Cell Transplantation
Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma  Taewoong Choi, Murali K. Kodali, Wen-Kai Weng 

Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma  Taewoong Choi, Murali K. Kodali, Wen-Kai Weng 
Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia  Katerina Ancevski,

Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia  Katerina Ancevski,
Richard Gopez Ancheta, MD, Carol Burian, CCRP, William E

Richard Gopez Ancheta, MD, Carol Burian, CCRP, William E
Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma  Brian Hess, MD, Kathryn Trinkaus, Ph.D.,

Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma  Brian Hess, MD, Kathryn Trinkaus, Ph.D.,
Development of Pre-Transplant Facesheet for Improved Accuracy of Data Collection through Direct Clinical Oversight  Madhu Ragupathi, Jaskiran Kaur, Mostafizur.

Development of Pre-Transplant Facesheet for Improved Accuracy of Data Collection through Direct Clinical Oversight  Madhu Ragupathi, Jaskiran Kaur, Mostafizur.
Implementation of Post-Transplant Assessment Tools for Improved Accuracy of Graft- Versus-Host Disease Reporting  Madhu Ragupathi, Jaskiran Kaur, Luda.

Implementation of Post-Transplant Assessment Tools for Improved Accuracy of Graft- Versus-Host Disease Reporting  Madhu Ragupathi, Jaskiran Kaur, Luda.
Optimizing Data Collection for Long-Term Follow-Up after Hematopoietic Stem Cell Transplant  Jaskiran Kaur, Madhu Ragupathi, Alysa Pleiner, Luda Kushner,

Optimizing Data Collection for Long-Term Follow-Up after Hematopoietic Stem Cell Transplant  Jaskiran Kaur, Madhu Ragupathi, Alysa Pleiner, Luda Kushner,
CD34-Selected, T Cell Depleted Haploidentical Donor Peripheral Blood Stem Cell (PBSC) Transplantation in Children with Malignant (MD) and Non-Malignant.

CD34-Selected, T Cell Depleted Haploidentical Donor Peripheral Blood Stem Cell (PBSC) Transplantation in Children with Malignant (MD) and Non-Malignant.
Eltrombopag Eliminates Transfusion Requirements in a Patient with Fanconi Anemia  Ashish Gupta, MD, MPH, Rasmi Palassery, MD, Sanjay Ahuja, MD, MBA, Rachel.

Eltrombopag Eliminates Transfusion Requirements in a Patient with Fanconi Anemia  Ashish Gupta, MD, MPH, Rasmi Palassery, MD, Sanjay Ahuja, MD, MBA, Rachel.
Geoffrey Barkley, LCSW, PhD, Julie Perry, M.Div, Chaplaincy 

Geoffrey Barkley, LCSW, PhD, Julie Perry, M.Div, Chaplaincy 
Let Them Eat! Comparing a Neutropenic Diet to a Food Safety Based Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)  Cynthia.

Let Them Eat! Comparing a Neutropenic Diet to a Food Safety Based Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)  Cynthia.
Jane Kempenich, Kelly Buck, John Hermanson, Jason Dehn, MPH 

Jane Kempenich, Kelly Buck, John Hermanson, Jason Dehn, MPH 
Treatment of Severe Mucositis Pain with Oral Ketamine Mouthwash

Treatment of Severe Mucositis Pain with Oral Ketamine Mouthwash
A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination Model  Justin N. Baker,

A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination Model  Justin N. Baker,
Pulse Cyclophosphamide for Steroid-Refractory Chronic Graft-Versus-Host Disease  Nelson J. Chao, MD, MBA, Yevgeniya Gora Foster, MD, Krista Rowe, RN, MSN,

Pulse Cyclophosphamide for Steroid-Refractory Chronic Graft-Versus-Host Disease  Nelson J. Chao, MD, MBA, Yevgeniya Gora Foster, MD, Krista Rowe, RN, MSN,
Optimizing Outcomes Beyond Day +100: Process for Identifying and Managing High- Risk Allogeneic Transplant Recipients  Sheila Serafino, Navneet S. Majhail,

Optimizing Outcomes Beyond Day +100: Process for Identifying and Managing High- Risk Allogeneic Transplant Recipients  Sheila Serafino, Navneet S. Majhail,
Early Use of Inhaled Ribavirin Can Improve Outcomes in High Risk Hematopoietic Stem Cell Transplant and Leukemia Patients with RSV Infection  Ron Mihelic,

Early Use of Inhaled Ribavirin Can Improve Outcomes in High Risk Hematopoietic Stem Cell Transplant and Leukemia Patients with RSV Infection  Ron Mihelic,

Similar presentations

Ads by Google